Covenant Hills Treatment Center Mens Residential
-
Services:
- Substance use treatment
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- TB screening
- Male
- Short-term residential
- Residential/24-hour residential
- Long-term residential
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Individual counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Hepatitis education, counseling, or support
- Marital/couples counseling
- Family counseling
- State Substance use treatment agency
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Prescribes naltrexone
- Federal military insurance (e.g., TRICARE)
- IHS/Tribal/Urban (ITU) funds
- Private health insurance
- Cash or self-payment
- Cognitive behavioral therapy
- Anger management
- 12-step facilitation
- Relapse prevention
- Substance use disorder counseling
- Matrix Model
- Trauma-related counseling
- Brief intervention
- Telemedicine/telehealth therapy
- Motivational interviewing
- Aftercare/continuing care
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Seniors
- Young Adults
- Adults
- Self-help groups
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Employment counseling or training
- Vaping permitted in designated area
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- Nicotine replacement
- Medications for HIV treatment
- Medication for mental disorders
- Naltrexone (oral)
- Clonidine
- Acamprosate (Campral®)
- Disulfiram
- Naltrexone (extended-release, injectable)
- Medications for pre-exposure to prophylaxis
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Buprenorphine (extended-release, injectable)
- Comprehensive mental health assessment
- Screening for mental disorders
- Screening for substance use
- Comprehensive substance use assessment
- Screening for tobacco use
- Outreach to persons in the community
- Smoking permitted in designated area
- Adult men
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Integrated primary care services
- Mental health services
- Social skills development
- Suicide prevention services
- Case management service
- Transportation assistance
- Private for-profit organization
Type of Care
Testing
Gender Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Education and Counseling Services
License/Certification/Accreditation
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Treatment Approaches
Transitional Services
Opioid Medications used in Treatment
Age Groups Accepted
Recovery Support Services
Facility Vaping Policy
External Opioid Medications Source
Pharmacotherapies
Assessment/Pre-treatment
Facility Smoking Policy
Special Programs/Groups Offered
Type of Alcohol Use Disorder Treatment
Ancillary Services
Facility Operation (e.g., Private, Public)